腹腔镜左侧切片切除术:在肝圆韧带和脐裂静脉的引导下
2024年9月27日
1.7K 次观看
腹腔镜左外侧断面切除术由圆韧带、肝韧带和脐裂静脉引导，即使没有控制低中心静脉压，也能有效控制术中出血，并防止实质夹层时失去方向。
我的研究重点是肝胆和胰腺肿瘤的微创手术治疗。在肝圆韧带和脐裂静脉的引导下，这种腹腔镜左侧横切术可有效控制术中出血，即使在没有受控的低中心静脉压的情况下也是如此。这些属性为患有心血管或脑血管疾病的患者提供了潜在的益处。
先进的成像方式，如吲哚菁绿荧光成像，可以提供胆道解剖结构的实时可视化，有助于手术计划和决策。我们技术的优势在于它避免了肝门夹层。其次，在肝实质解剖过程中，我们利用脐裂静脉的肝内解剖标志作为引导，以防止方向丢失。
概述
本文讨论了一种利用肝圆韧带和脐静脉作为解剖学导向的腹腔镜左侧肝叶切除术技术。该方法有效控制了术中出血，并在肝实质分离过程中保持了方向。
关键研究组成部分
科学领域
- 微创手术
- 肝胆外科
- 肿瘤学
背景
- 微创技术对于缩短患者恢复时间至关重要。
- 术中出血控制在肝脏手术中至关重要。
- 先进的成像技术有助于手术精确度。
- 了解肝脏解剖对于成功的手术结果至关重要。
研究目的
- 展示一种能够在肝脏手术中最小化出血的技术。
- 利用解剖学标志物进行更好的手术导航。
- 评估对心血管或脑血管疾病患者的益处。
使用的方法
- 腹腔镜左侧肝叶切除术程序。
- 由肝圆韧带和脐静脉导向。
- 用于实时可视化的吲哚菁绿荧光成像。
- 避免肝脏蒂部解剖。
主要结果
- 在不使用低中心静脉压的情况下有效控制术中出血。
- 使用肝内解剖标志物改善了手术导航。
- 对特定心血管疾病患者可能带来的益处。
- 通过先进成像技术增强了手术计划。
结论
- 该技术为肝脏手术提供了可靠的方法。
- 利用解剖学标志物可以防止手术过程中的方向失误。
- 进一步的研究可能探索适用于各种患者群体的更广泛应用。
常见问题
什么是腹腔镜左侧肝叶切除术？
它是一种微创手术程序，用于移除肝脏的一部分。
这种技术如何控制出血？
通过使用解剖学标志物来引导手术，它最大限度地降低了对血管的损伤风险。
成像在这个手术中扮演什么角色？
先进的成像技术提供了肝脏解剖的实时可视化，有助于手术计划。
谁可以从这种手术方法中受益？
心血管或脑血管疾病患者可能从降低出血风险中受益。
避免肝脏蒂部解剖有什么优势？
它降低了手术的复杂性，并最大限度地减少了潜在的并发症。
这种技术被广泛使用吗？
它正因其在微创肝脏手术中的有效性而获得认可。
Executive Industry Relevance
Precise anatomical guidance in laparoscopic left lateral sectionectomy (LLLS) addresses a critical challenge in minimizing intraoperative bleeding, especially when controlled low central venous pressure is contraindicated. Leveraging the ligamentum teres hepatis and umbilical fissure vein as landmarks enhances surgical accuracy and safety, supporting broader applicability across patient populations. This approach strengthens procedural predictability and operational confidence at key inflection points in surgical innovation pipelines.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables mechanistic de-risking by clarifying anatomical pathways relevant to surgical intervention.
- Supports functional validation of anatomical landmarks for procedural reproducibility.
- Facilitates predictive confidence in surgical outcomes by standardizing intraoperative navigation.
Screening & Assay Development
- Prepares validated anatomical models for evaluating surgical devices or imaging agents.
- Promotes reproducibility and standardization in preclinical surgical simulation studies.
- Enables quantitative assessment of intraoperative bleeding and navigation accuracy.
Translational & Preclinical Research
- Aligns surgical models with disease-relevant anatomical features for translational continuity.
- Supports risk-adjusted advancement of minimally invasive surgical techniques.
- Provides a platform for evaluating intraoperative imaging and navigation technologies.
Pipeline & Workflow Integration
This anatomical-guided LLLS method integrates into the surgical innovation continuum from preclinical model development to translational research and device evaluation.
- Discovery Biology: Clarifies anatomical targets and pathways for surgical intervention.
- Screening: Establishes reproducible models for device and imaging agent assessment.
- Analytics: Enables quantitative measurement of intraoperative bleeding and navigation precision.
- Translational Research: Bridges preclinical findings with clinical procedural standards.
- Enterprise Reuse: Provides a standardized approach adaptable across surgical research programs.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces procedural ambiguity in surgical models.
- Operational Value: Enhances reproducibility and standardization in surgical research workflows.
- Strategic Value: Improves decision-making for surgical technique adoption and device development.
- Portfolio Impact: Supports risk-adjusted prioritization of minimally invasive surgical innovations.
Implementation Considerations
- Requires expertise in hepatobiliary anatomy and minimally invasive surgical techniques.
- Demands access to advanced imaging modalities for intraoperative guidance.
- Necessitates cross-team standardization of anatomical landmark identification.
- Adaptation may be needed for anatomical variability across preclinical models.
- Limitations include dependency on imaging quality and operator proficiency.
Biopharma FAQs
Why does null hypothesis testing matter for anatomical landmark validation?
Null hypothesis testing ensures that observed reductions in intraoperative bleeding are statistically attributable to the use of ligamentum teres hepatis and umbilical fissure vein guidance, rather than procedural variability or chance.
How does independent variable isolation fit surgical navigation studies?
Isolating the use of specific anatomical landmarks as independent variables allows teams to directly assess their impact on navigation accuracy and bleeding control, supporting robust procedural optimization.
What do quantitative bleeding measurements enable in LLLS research?
Quantitative dependent variable measurements, such as intraoperative blood loss, enable objective comparison of surgical techniques and inform go/no-go decisions for procedural adoption.
Why are replication requirements critical for cross-team surgical studies?
Replication ensures that anatomical-guided LLLS outcomes are reproducible across operators and settings, facilitating cross-functional collaboration and enterprise-wide procedural standardization.
What statistical analysis capabilities are needed before procedural implementation?
Robust statistical analysis, including hypothesis testing and variance assessment, is required to validate that anatomical guidance reliably improves surgical outcomes before broader implementation in research or clinical settings.
